References
- 1. R. Romagnoli, P. G. Baraldi, C. Lopez-Cara, M. K. Salvador, D. Preti, M. A. Tabrizi, J. Balzarini, P. Nussbaumer, M. Bassetto, A. Brancale, X. H. Fu, Y. Gao, J. Li, S. Z. Zhang, E. Hamel, R. Bortolozzi, G. Basso and G. Viola, Design, synthesis and biological evaluation of 3,5-disubstituted 2- aminothiophene derivatives as a novel class of antitumor agents, Bioorg. Med. Chem. 22 (2014) 5097-5109; DOI: 10.1016/j.bmc. 2013.12.030.
- 2. R. Romagnoli, P. G. Baraldi, M. D. Carrion, C. L. Cara, D. Perti, F. Fruttarolo, M. G. Pavani, M. A. Tabrizi, M. Tolomio, S. Grimaudo, A. Di Cristina, J. Balzarini, J. A. Hadfield, A. Bracale and E. Hamel, Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization, J. Med. Chem. 50 (2007) 2273-2277; DOI: 10.1021/jm070050f.
- 3. C. E. Stephens, T. M. Felder, J. W. Sowell, G. Andrei, J. Balzarini, R. Snoeck and E. De Clercq, Synthesis and antiviral/antitumor evaluation of 2-amino- 2-carboxamido-3-aryl- sulfonylthiophenes and related compounds as a new class of diarylsulfones, Bioorg. Med. Chem. 9 (2001) 1123-1132; DOI: 10.1016/S0968-0896(00)00333-3.
- 4. S. Sulzer-Mosse, F. Cederbaum, C. Lamberth, G. Berthon, J. Umarye, V. Grasso, A. Schlereth, M. Blum and R. Waldmeier, Synthesis and fungicidal activity of N-thiazol-4-yl-salicylamides, a new family of anti-oomycete compounds, Bioorg. Med. Chem. 23 (2015) 2129-2138; DOI: 10.1016/j. bmc.2015.03.007.
- 5. V. Padmavathi, C. Prema Kumari, B. C. Venkatesh and A. Padmaja, Synthesis and antimicrobial activity of amido linked pyrrolyl and pyrazolyl-oxazoles, thiazoles and imidazoles, Eur. J. Med. Chem. 46 (2011) 5317-5326; DOI: 10.1016/j.ejmech.2011.08. 032.
- 6. M. B. Dewal, A. S. Wani, C. Vidaillac, D. Oupický, M. J. Rybak and S. M. Firestine, Thieno[2,3-d] pyrimidinedione derivatives as antibacterial agents, Eur. J. Med. Chem. 51 (2012) 145-153; DOI: 10.1016/j.ejmech.2012.02.035.
- 7. A. T. Mavrova, D. Wesselinova, J. A. Tsenov and L. A. Lubenov, Synthesis and antiproliferative activity of some new thieno[2,3-d]pyrimidine-4-(3H)-ones containing 1,2,4-triazole and 1,3,4-thiadiazole moiety, Eur. J. Med. Chem. 86 (2014) 676-683; DOI: 10.1016/j.ejmech.2014.09.032.
- 8. F. Chimenti, B. Bizzarri, A. Bolasco, D. Secci, P. Chimenti, S. Carradori, A. Granese, D. Rivanera, D. Lilli, A. Zicari, M. M. Scaltrito and F. Sisto, A novel class of selective anti-Helicobacter pylori agents 2-oxo-2H-chromene-3-carboxamide derivatives, Bioorg. Med. Chem. Lett. 17 (2007) 3065-3071; DOI: 10.1016/j.bmcl. 2007. 03.050.
- 9. S. Bindi, D. Fancelli, C. Alli, D. Berta, J. A. Bertrand, A. D. Cameron, P. Cappella, P. Carpinelli, G. Cervi, V. Croci, M. D’Anello, B. Forte, M. L. Giorgini, A. Marsiglio, J. Moll, E. Pesenti, V. Pittalà, M. Pulici, F. Riccardi-Sirtori, F. Roletto, C. Soncini, P. Storici, M. Varasi, D. Volpi, P. Zugnoni and P. Vianello, Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity, Bioorg. Med. Chem. 18 (2010) 7113-7120; DOI: 10.1016/j.bmc.2010.07.048.
- 10. S. Ulloora, R. Shabaraya, R. Ranganathan and A. V. Adhikari, Synthesis, anticonvulsant and antiinflammatory studies of new 1,4-dihydropyridin-4-yl-phenoxyacetohydrazones, Eur. J. Med. Chem. 70 (2013) 341-349; DOI: 10.1016/j. ejmech.2013.10. 010.
- 11. A. A. Napoleon, F. R. N. Khan, E. D. Jeong and E. H. Chung, Potential antitubercular agents: Hexahydro-3-phenyl indazol-2-yl-(pyridine-4-yl) methanones from antitubercular drug isoniazid and bis(substituted benzylidene) cycloalkanones, Chin. Chem. Lett. 26 (2015) 567-571; DOI: 10.1016/j.cclet.2015.01.008.
- 12. S. Malik, P. Ahuja, K. Sahu and S. A. Khan, Design and synthesis of new 3-(benzo [d] isoxazol-3yl)-1-substituted pyrrolidine-2,5-dione derivatives as anti-convulsants, Eur. J. Med. Chem. 84 (2014) 42-50; DOI: 10.1016/j.ejmech.2014.07.016
- 13. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer Inst. 82 (1990) 1107-1112; DOI: 10.1093/jnci/82.13.1107.
- 14. A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Paull, D. Vistica, C. Hose, J. Langley, P. Cronise, A. Vaigro-Wolff, M. Gray-Goodrich, H. Campbell, J. Mayo and M. J. Boyd, Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines, J. Natl. Cancer Inst. 83 (1991) 757-766; DOI: 10.1093/jnci/83.11.757.